Posted: Feb 22, 2021 5:00 AM CT | Last Updated: February 22
As part of a plea agreement, two California cancer physicians have admitted they bought unapproved, counterfeit oncology drugs from a company owned by a Winnipeg internet pharmacy pioneer. The Altuzan, also known as Avastin, is an injectable cancer medication. It was found to have no active ingredients. (U.S. Food and Drug Administration)
Two California oncologists have agreed to plead guilty in a case involving the purchase of more than $1 million US in unapproved and counterfeit cancer drugs from a company owned by a Winnipeg internet pharmacy pioneer.
Dr. Stanley Rossman and Dr. Mark Goldstein of Hematology Oncology Consultants will be back in a Los Angeles court March 19.
Canada
California
United-states
Montana
Orange-county
Canadian
Kris-thorkelson
Los-angeles
Stanley-rossman
Scott-schwebke
Shabbir-safdar
Mark-goldstein
19-Feb-2021
Two oncology specialists in California, US, have agreed to plead guilty to federal charges related to the distribution of unapproved copies of a Roche cancer medicine.
Drs Stanley Rossman and Mark Goldstein are expected to plead guilty later today to obtaining more than $1m-worth of Altuzan – an overseas name for Roche’s big-selling Avastin brand – that was at the centre of a major falsified medicines scandal a few years ago, according to an
Orange County Register report.
The two physicians could face suspension or revocation of their licenses to practice medicine and up to $1.2m in fines, according to the news platform.
Turkey
California
United-states
Orange-county
Turkish
Ronald-noble
Stanley-rossman
Mark-goldstein
Cypru-ministry-of-health
Orange-county-register
Cypru-ministry